We are live on
!
Find out more
RXII
GALENA BIOPHARMA INC COM
RXII
RXII
Delisted
RXII was delisted on the 25th of October, 2011.
73 hedge funds and large institutions have $40.5M invested in GALENA BIOPHARMA INC COM in 2013 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
260% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 5
183% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 12
38% more capital invested
Capital invested by funds: $29.3M → $40.5M (+$11.2M)
29% more call options, than puts
Call options by funds: $4.13M | Put options by funds: $3.2M
22% more funds holding
Funds holding: 60 → 73 (+13)
Holders
73
Holders Change
+13
Holders Change %
+21.67%
% of All Funds
2.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
34
Reduced
12
Closed
5
Calls
$4.13M
Puts
$3.2M
Net Calls
+$931K
Net Calls Change
+$392K
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$957K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$800K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$771K |
| 4 |
Goldman Sachs
New York
|
-$495K |
| 5 |
JP Morgan Chase
New York
|
-$164K |
